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C L I N I C A L  I N V E S T I G A T I O N
Chronic post-operative opioid use after open cardiac surgery: A 
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Editorial Comment: Prolonged post-operative patient opioid use occurs, though clinicians should strive to help patients avoid this to promote optimal recovery. In this regional, 
registry-based, retrospective analysis, chronic post-operative opioid use after open cardiac surgery was identified in approximately 1 in 20 pre-operatively opioid-naive patients, but in a 
majority of patients who used opioids pre-operatively.  
1Department of Clinical Epidemiology, 
Aarhus University Hospital, Aarhus, 
Denmark
2Department of Anesthesiology and 
Intensive Care, Aarhus University Hospital, 
Aarhus, Denmark
3Public Health and Epidemiology, 
Department of Health Science and 
Technology, Aalborg University, Aalborg, 
Denmark
4Unit of Clinical Biostatistics, Aalborg 
University Hospital, Aalborg, Denmark
5Department of Cardiothoracic Surgery, 
Aarhus University Hospital, Aalborg, 
Denmark
Correspondence
Kasper Bonnesen, Irma Pedersens Gade 
131, 3. tv., 8000. Aarhus C, Denmark.
Email: bonnesen@clin.au.dk
Funding information
Health Research Fund of the Central 
Denmark Region
Abstract
Background: Knowledge of chronic opioid use after cardiac surgery is sparse. We 
therefore aimed to describe the proportion of new chronic post-operative opioid use 
after open cardiac surgery.
Methods: We used prospectively registered data from a national prescription reg-
istry and a clinical registry of 29 815 first-time cardiac surgeries from three Danish 
university hospitals. Data collection spanned from 2003 to 2016. The main outcome 
was chronic post-operative opioid use, defined as at least one opioid dispensing in 
the fourth post-operative quarter. Data were assessed for patient-level predictors of 
chronic post-operative opioid use, including pre-operative opioid use, opioid use at 
discharge, comorbidities, and procedural related variables.
Results: The overall proportion of post-operative opioid use was 10.6% (95% CI: 
10.2-10.9). The proportion of new chronic post-operative opioid use was 5.7% (95% 
CI: 5.5-6.0) among pre-operative opioid naïve patients. The corresponding propor-
tions among patients, who pre-operatively used low or high dose opioid (1-500 mg 
or > 500 mg cumulative morphine equivalent opioid), were 68.3% (95% CI: 66.1-70.4) 
and 76.3% (95% CI: 74.0-78.5) respectively. Risk factors associated with new chronic 
post-operative opioid use included: female gender, underweight and obesity, pre-
operative comorbidities, acute surgery, ICU-time > 1 day, and post-operative compli-
cations. Strongest predictor of chronic post-operative opioid use was post-discharge 
use of opioid within one month after surgery (odds ratio 3.3, 95% CI: 2.8-4.0).
Conclusion: New chronic post-operative opioid use after open cardiac surgery is 
common. Focus on post-discharge opioid use may help clinicians to reduce rates of 
new chronic opioid users.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, 
provided the original work is properly cited. 
© 2020 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley & Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation
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1  | INTRODUC TION
Opioid use is a serious healthcare concern globally as well as in 
Denmark.1-3 Denmark has one of the highest rates of opioid con-
sumption in the world with 3%-5% of all Danes using opioid reg-
ularly.4 This is concerning as chronic opioid use is associated with 
increased risk of opioid-related morbidity and mortality.5-7 As one 
common indication for opioid prescriptions, special attention should 
be devoted toward opioid prescribing following surgical procedures.8
In Denmark, approximately 4000 cardiac surgeries involving 
sternotomy are performed annually.9 The use of intraoperative opi-
oid treatment following cardiac surgery is necessary to alleviate pain 
caused by artery harvesting, rib retraction, sternotomy, and drain 
tubes.10 Effective intraoperative pain management may reduce 
post-operative complications such as myocardial infarction, cardiac 
arrhythmias, hypercoagulability, and pulmonary complications.10,11 
While opioids may be necessary to control pain in the intraopera-
tive period, studies suggest that the harms of opioid use after hos-
pital discharge may outweigh the benefits, as post-operative opioid 
use has been associated with chronic opioid use, misuse, opioid use 
disorder, overdose, and cognitive dysfunction.12-15 In fact, several 
studies show that 3-10% of patients who did not take opioids before 
surgery develop a chronic opioid use after surgery.16-18
Several risk factors for chronic post-operative opioid use have 
been identified including male gender, older age, medical and psychi-
atric comorbidities, concomitant benzodiazepine use, and type and 
extent of surgery, among others.16,17,19,20 Although previous studies 
have examined the associations between various types of surgeries 
and long-term opioid use, the knowledge of chronic post-operative 
opioid use after cardiac surgery is sparse.
We aimed to examine patterns of opioid use within the first year 
after open cardiac surgery and estimate the risk of chronic post-op-
erative opioid use according to pre-, intra-, and post-operative 
characteristics.
2  | MATERIAL S AND METHODS
2.1 | Study design and setting
This population-based cohort study used prospectively collected 
data from medical and administrative registries in Western Denmark. 
Western Denmark has a population of approximately 3.3 million 
people corresponding to 55% of the total Danish population.21 
Danish citizens are assigned a unique 10-digit Civil Personal Register 
number allowing linkage of Danish registries on an individual level.22
The study was approved by the Danish Data Protection Agency 
(Case no.: 1-16-02-42-18) and the Danish Patient Safety Authority 
(Case no. 3-3013-2491/1). Approval by the local ethics commit-
tee and collection of informed consent are not required for regis-
ter-based studies in Denmark.
2.2 | Data sources
Patients were identified from the Western Denmark Heart Registry 
(WDHR)—a mandatory internet-based clinical registry covering all 
adult patients undergoing cardiac surgery in Western Denmark. 
Detailed patient, surgery, anesthesia, and intensive care data are 
prospectively collected on consecutive patients.21,23 Data on opioid 
dispensing were retrieved from the National Prescription Registry 
(NPR)—a registry containing detailed nationwide information about 
patient, dispensing, prescriber, and pharmacy information on re-
deemed prescriptions since 1995.24 Data in both WDHR and NPR 
are considered both complete and valid.21,23,25 Baseline characteris-
tics were identified from the WDHR using EuroSCORE I15 and 2013 
EuroSCORE II.16 The specific definitions of the Euroscore I and II can 
be seen elsewhere.15;16
The Danish Health Service provides universal tax-supported 
healthcare, guaranteeing all Danish residents free access to general 
practitioners and hospitals. In Denmark, general practitioners issue 
most prescriptions. Patient co-payment is required for prescription 
drugs. Any reimbursable medicines are covered by a tax-financed 
drug reimbursement scheme.26
2.3 | Study population
The study included all first-time cardiac surgical procedures con-
ducted in the three university hospitals in Western Denmark from 
January 1, 2003 to December 31, 2016. Availability of data in the 
Danish Prescription Database defined the chosen time-period. 
Prior to study-time restriction, patients with missing data on time 
of surgery (n = 7) and patients with an invalid Central Personal 
Registration number were excluded (n = 223). After study-time re-
striction, all non-first-time procedures, or if the surgical procedure 
did not involve sternotomy or was a heart transplantation were ex-
cluded (Figure 1).
All patients completed the 1-year follow-up. Missing data on 
pre-, intra-, and post-operative characteristics ranged from 2.5% to 
8.4%.
2.4 | Outcome
Opioid dispensings were identified from 6 months before surgery to 
12 months after surgery. We defined the primary outcome “chronic 
post-operative opioid use” a priori before data extraction. We di-
vided opioid use into four 3-month periods (quarters) after surgery 
and defined opioid use as at least one opioid dispensing in one of 
these quarters. We defined chronic post-operative opioid use as at 
least one opioid dispensing in the fourth post-operative quarter. We 
defined late initiators as individuals with a first opioid dispensing 
later than three months after surgery.
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2.5 | Covariates
Included covariates were defined a priori before data extraction. 
Pre-operative opioid use was included as a possible risk factor for 
chronic post-operative opioid use. Pre-operative opioid use was 
defined as at least one opioid dispensing within 6 months before 
cardiac surgery. We further divided pre-operative opioid use 
into low (≤500 mg) or high dose (>500 mg) based on cumulative 
morphine equivalent opioid use within 6 months before cardiac 
surgery. Patients’ descriptive and clinical characteristics were col-
lected at the time of cardiac surgery. Pre-operative demographic 
and clinical characteristics included gender, age group (<60, 60-70, 
and > 70), BMI (<18.5, 18.5-24.9, 25.0-29.9, and > 30.0), chronic 
obstructive pulmonary disease, peripheral artery disease, chronic 
kidney failure, diabetes, left ventricle ejection fraction (≥50, 31-50, 
and ≤ 30), and pulmonary hypertension. Intraoperative character-
istics included acute surgery, surgery type (coronary artery by-
pass grafting without valve surgery and combinations and other), 
epidural anesthesia, extra corporal circulation, and intensive care 
unit (ICU) time more than one day. Post-operative characteristics 
included myocardial infarction, renal replacement therapy, reop-
eration, sternal wound infection, and stroke. We defined post-
discharge opioid use as cumulative morphine equivalent opioid 
(OME) use within one month after cardiac surgery and divided this 
into 0, 1-500 mg, and > 500 mg.
2.6 | Statistical analyses
Proportions and numbers are used to describe the study popula-
tion stratified by opioid naïve patients and opioid users before sur-
gery. Categorical data are presented as numbers and percentages 
(%) with an estimated 95% confidence interval (CI). Comparisons 
of categorical data were made using a chi-squared test and results 
with a P-value < .05 were considered significant. Continuous data 
are presented as means with a 95% CI for normally distributed 
data and as medians with interquartile ranges for skewed data. 
Patients had to be alive on the last day of each of the four post-
operative quarters to be included in the calculation for that par-
ticular period. Logistic regression was applied to estimate odds 
ratios (OR) and 95% CI of chronic post-operative opioid use ac-
cording to pre-, intra-, and post-operative patient characteristics. 
ORs were stratified according to pre-operative opioid use in order 
to minimize any risk of effect modification. Crude estimates with 
95% CIs were reported. All statistical analyses were conducted in 
SAS version 9.4.
F I G U R E  1   Flowchart of cohort 
inclusion, western Denmark, 2003–2016. 
*No opioid dispensing within six months 
before cardiac surgery
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3  | RESULTS
3.1 | Cohort characteristics
Among 29,815 patients who had open cardiac surgery between 
2003 and 2016 in Western Denmark, 26,202 (87.9%) were pre-
operative opioid naïve and 3609 (12.1%) were pre-operative opioid 
users (Table 1). Pre-operative opioid users were more likely to be 
female, to be obese, or to have a diagnosis of chronic obstructive 
pulmonary disease, peripheral artery disease, diabetes, or pulmo-
nary hypertension (all P < .01). Less pre-operative opioid users were 
alive and the end of the fourth post-operative quarter (90% com-
pared to 94% of pre-operative opioid naïve patients). Pre-operative 
opioid users were more likely to have acute surgery, to have an ICU-
time > 1 day, or to be under extracorporeal circulation during the 
operation (all P < .01). Pre-operative opioid users had a higher fre-
quency of post-operative myocardial infarction (P = .04), renal re-
placement therapy (0 < 0.01), and sternal wound infection (P < .01).
3.2 | Chronic post-operative opioid use
The overall proportion of chronic post-operative opioid use was 10.6% 
(95% CI: 10.2-10.9). The proportion of chronic post-operative opioid use 
was 5.7% (95% CI: 5.5-6.0) in pre-operative opioid naïve patients, 68.3% 
(95% CI: 66.1-70.4) in pre-operative low dose opioid users, and 76.3% 
(95% CI: 74.0-78.5) in pre-operative high dose opioid users (Table 2).
Among chronic post-operative opioid users, late initiators (first 
opioid dispensing later than three months after surgery) accounted 
for 52.5% in pre-operative opioid naïve patients and 15.6% in 
pre-operative opioid users (Figure 2).
The overall proportions of chronic post-operative opioid use was 
10.9% (95% CI: 10.6-11.3) in the second post-operative quarter, 10.6% 
(95% CI: 10.2-10.9) in the third post-operative quarter, and 10.6% (95% 
CI: 10.2-10.9) in the fourth post-operative quarter. The proportion of opi-
oid use remained steady from the second until the fourth post-operative 
quarter for both pre-operative opioid naïve patients, pre-operative low 
dose opioid users, and pre-operative high dose opioid users (Table 2).
Among chronic post-operative opioid users, 57% had ≥ 5 opioid 
dispensings in the fourth post-operative quarter; 12% had one dis-
pensing (Figure ). The proportion of chronic post-operative opioid 
users remained steady during the years studied (Figure 4). Opioid 
dispensing in the first post-operative quarter decreased from 39% 
in 2003 to 29% in 2016. Tramadol accounted for approximately half 
of all opioid dispensings. Morphine, Oxycodone, and Codeine were 
also commonly dispensed (Table A3 in the appendix).
3.3 | Risk factors for chronic post-operative 
opioid use
Pre-operative opioid use was highly associated with chronic post-
operative opioid use (OR = 14.5, 95% CI: 13.3-15.8). Cumulative 
TA B L E  1   Characteristics of patients subjected to open cardiac 
surgery, stratified by pre-operative opioid status, Western 
Denmark, 2003-2016
All patients, 
n (%)
Opioid 
naïvea , n (%)
Opioid 
user, n (%)
Total
29 815 
(100) 26 206 (100) 3609 (100)
1a. Baseline characteristics
Gender
Female 7753 (26.0) 6486 (24.8) 1267 (35.1)
Missing 928 (3.1) 782 (3.0) 146 (4.1)
Age
<60 years 6824 (22.9) 6044 (23.1) 780 (21.6)
60−70 years 9228 (31.0) 8197 (31.3) 1031 (28.6)
>70 years 12 971 
(43.5)
11 299 (43.1) 1672 (46.3)
Missing 792 (2.7) 666 (2.5) 126 (3.5)
BMI
<18.5 14.10 (4.7) 1219 (4.7) 191 (5.3)
18.5-24.9 8582 (28.8) 7620 (29.1) 962 (26.7)
25.0-29.9 11 523 
(38.7)
10 255 (39.1) 1268 (35.1)
>30.0 5993 (20.2) 5109 (19.5) 884 (24.5)
Missing 2307 (7.7) 2003 (7.6) 304 (8.4)
Euroscore
Median (IQR) 5 (3-8) 5 (3-8) 5 (4-9)
Missing 928 (3.1) 782 (3.0) 146 (4.0)
Chronic obstructive pulmonary disease
Yes 3,185 (10.7) 2,630 (10.0) 555 (15.4)
Missing 1004 (3.4) 844 (3.2) 160 (4.4)
Peripheral artery disease
Yes 2807 (9.4) 2309 (8.8) 498 (13.8)
Missing 997 (3.3) 840 (3.2) 157 (4.4)
Chronic kidney failureb 
Yes 748 (2.5) 610 (2.3) 138 (3.8)
Missing 1052 (3.5) 889 (3.4) 163 (4.5)
Diabetesc 
Yes 4223 (14.2) 3583 (13.7) 640 (17.7)
Missing 1478 (5.0) 1269 (4.8) 209 (5.8)
Left ventricle ejection fraction
≥50 17 364 
(58.2)
15 277 (58.3) 2087 (57.8)
31-50 9467 (31.8) 8342 (31.8) 1125 (31.2)
≤30 1866 (6.3) 1,640 (6.3) 226 (6.3)
Missing 1118 (3.8) 947 (3.6) 171 (4.7)
Pulmonary hypertension
Yes 2357 (7.9) 2021 (7.7) 336 (9.3)
Missing 1461 (4.9) 1245 (4.8) 216 (6.0)
(Continues)
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post-discharge OME use of more than 500 mg was highly associated 
with increased risk of chronic post-operative opioid use in pre-oper-
ative opioid naïve patients (OR = 3.3, 95% CI: 2.8-4.0). Several pre-, 
intra-, and post-operative factors were associated with increased 
risk of becoming a new chronic post-operative opioid user including 
female gender, low and high BMI, pre-operative comorbidities, acute 
surgery, prolonged ICU stay, and post-operative complications such 
as sternal wound infection, need of renal replacement therapy, and 
stroke (Figure 5).
4  | DISCUSSION
4.1 | Opioid use distribution
In this retrospective study of opioid use after open cardiac surgery, 
we found chronic post-operative opioid use, defined as at least one 
opioid dispensing in the fourth post-operative quarter, in 5.7% (95% 
CI: 5.5-6.0) of opioid naïve patients and 46.9% (95% CI: 45.2-48.7) of 
pre-operative opioid users. Opioid use remained steady as from the 
second post-operative quarter.
To our knowledge, only two previous studies, both conducted 
in the United States, have investigated chronic post-operative opi-
oid use after cardiac surgery. One retrospective study followed 
330 patients undergoing isolated coronary artery bypass grafting. 
Chronic post-operative opioid use (defined as at least one opioid 
dispensing beyond 90 days after surgery) was 21.7% for pre-oper-
ative opioid users and 3.2% and for opioid naïve participants (fol-
low-up time was one year).27 Comparison with the present study 
is hampered by the small study population, short follow-up, and 
lack of data on actual opioid dispensing.27 Another retrospective 
study followed opioid naïve Medicare patients undergoing car-
diothoracic surgery (coronary artery bypass grafting and/or valve 
repair/replacement) 6 months after surgery. Chronic post-opera-
tive opioid use was seen in 12.8% of patients.28 Methodological 
differences rather than national differences in pain following car-
diac surgery may explain this difference. First, these differences 
may be attributed to the timing and definition used for the pri-
mary outcome of chronic post-operative opioid use. Second, the 
American population was limited to Medicare beneficiaries, with 
the inherent risk of selection bias. Finally, several studies have 
shown significant disparities between the quantity of opioids 
prescribed and actual consumption after surgery. A recent study 
described a median consumption of 27% of the opioid amount 
prescribed across 12 different surgical procedures.29 Classifying 
All patients, 
n (%)
Opioid 
naïvea , n (%)
Opioid 
user, n (%)
Total
29 815 
(100) 26 206 (100) 3609 (100)
Status fourth quarter
Alive 27 894 
(93.6)
24 638 (94.0) 3256 (90.2)
1b. Intraoperative characteristics
Acute surgery
Yes 2369 (8.0) 2060 (7.9) 309 (8.6)
Missing 931 (3.1) 784 (3.0) 147 (4.1)
Surgery type
CABG, 
without valve 
surgery
14 869 
(49.9)
13 225 (50.5) 1644 (45.6)
Combinations 
and other
14 124 
(47.4)
12 291 (46.9) 1833 (50.5)
Missing 822 (2.8) 690 (2.6) 132 (3.7)
Epidurald 
Yes 3588 (36.3) 3199 (36.7) 389 (33.5)
Missing 105 (1.1) 90 (1.0) 15 (1.3)
Extra corporeal 
circulation
Off pump 3551 (11.9) 3048 (11.6) 503 (13.9)
Missing 1463 (4.9) 1269 (4.8) 194 (5.4)
1c. Post-operative characteristics
ICU-time
≤1 day 22 136 
(74.2)
19 608 (74.8) 2528 (70.1)
Missing 1013 (3.4) 856 (3.3) 157 (4.4)
Myocardial infarction
Yes 793 (2.7) 681 (2.6) 112 (3.1)
Missing 1795 (6.0) 1554 (5.9) 241 (6.7)
Renal replacement therapye 
Yes 1105 (3.7) 934 (3.6) 171 (4.7)
Missing 2000 (6.7) 1745 (6.7) 255 (7.1)
Reoperation
Yes 1994 (6.7) 1,738 (6.6) 256 (7.1)
Missing 1055 (3.5) 893 (3.4) 162 (4.5)
Sternal wound infection
Yes 388 (1.3) 320 (1.2) 68 (1.9)
Missing 1975 (6.6) 1718 (6.6) 257 (7.1)
Stroke
Yes 600 (2.0) 523 (2.0) 77 (2.1)
Missing 1750 (5.9) 1511 (5.8) 239 (6.6)
Abbreviations: BMI, body mass index; CABG, coronary artery bypass 
grafting; ICU, intensive care unitIQR, interquartile range; n, number.
aNo opioid dispensing within six months before cardiac surgery. 
TA B L E  1   (Continued)
(Continues)
bDefined as serum creatinine > 200. 
cIncludes pharmacologically treated diabetes mellitus type 1 and type 2. 
dEpidural catheters were used in only one of the four heart centers 
(Odense). 
eIncludes hemodialysis, peritoneal dialysis, and continuous veno-venous 
hemofiltration. 
TA B L E  1   (Continued)
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chronic post-operative opioid use based on prescription dispens-
ing according to the NPR may represent a more accurate measure 
of medication intake, even in the presence of some misclassifica-
tion.30 The proportion of chronic post-operative opioid users did 
not change during the study period. However, a decrease in opi-
oid dispensing in the first post-operative quarter was observed. 
Recent years’ increased awareness of the opioid epidemic may 
explain this trend, causing doctors to change their prescribing 
practice. Interestingly, this decrease did not continue into the fol-
lowing post-operative quarters. The present data reflects opioid 
prescribing and chronic post-operative opioid use prior to initia-
tives launched by the Danish Health Authority in 2017 (and going 
forward) with the purpose to reduce rates of chronic opioid use in 
Denmark. Most recent national data from 2017 on overall chronic 
opioid use indicates that chronic opioid use in Denmark has been 
reduced by 7%. Accordingly, rates of chronic post-operative opi-
oid use after cardiac surgery may be less today than described by 
present data.
The 5.7% incidence of new chronic post-operative opioid users 
described in the present study is aligned with the reports published 
by Brummet et al describing that approximately 6% of patients 
undergoing other surgical conditions became new chronic opi-
oid users. Our results support their conclusions that new chronic 
post-operative opioid use is a common surgical complication that 
may be independent of the surgical burden.16 The stable opioid dis-
pensing proportions from the second to the fourth post-operative 
quarter along with the high number of opioid dispensing per patient 
both indicate an actual continuous opioid use among the individ-
uals, and not just a single prescription for a potentially different 
cause.
Total, n
All patients,
% (95% CI)
Opioid naïvea ,
% (95% CI)
Low dose opioid 
userb ,
% (95% CI)
High dose opioid 
userc ,
% (95% CI)
29 815 (100) 26 206 (100) 27 827 28 302
Post-operative quarter
Q1 28.6 (28.1-29.1) 24.2 (23.7-24.7) 76.8 (74.8-78.6) 82.6 (80.5-84.5)
Q2 10.9 (10.6-11.3) 5.9 (5.6-6.2) 69.9 (67.8-72.0) 77.3 (75.0-79.4)
Q3 10.6 (10.2-10.9) 5.6 (5.3-5.9) 69.0 (66.8-71.1) 76.2 (73.9-78.4)
Q4 10.6 (10.2-10.9) 5.7 (5.5-6.0) 68.3 (66.1-70.4) 76.3 (74.0-78.5)
Abbreviations: CI, confidence interval; n, number; Q, quarter.
aNo opioid dispensing within six months before cardiac surgery. 
bCumulative morphine equivalent opioid use within six months before cardiac surgery ≤ 500 mg. 
cCumulative morphine equivalent opioid use within six months before cardiac surgery > 500 mg. 
TA B L E  2   Post-operative opioid use 
by pre-operative opioid status, Western 
Denmark, 2003-2016
F I G U R E  2   Percentage of patients with an opioid dispensing and the proportion attributed to late initiators in each postoperative quarter 
stratified by preoperative opioid status, western denmark, 2003–2016. Abbreviations: Q, quarter. *No opioid dispensing within six months 
before cardiac surgery. †Defined as first postoperative opioid dispensing ≥3 months after cardiac surgery
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4.2 | Risk of opioid use
Pre-operative opioid users had an almost 14-fold increased risk of 
chronic post-operative opioid use compared with opioid naïve pa-
tients. Among opioid naïve patients who were dispensed an opioid 
in the first post-operative quarter, 76% were successful in becom-
ing opioid-free one year after surgery, in contrast with only 23% 
among opioid users. This is consistent with previous work that has 
identified pre-operative opioid use as one of the strongest indica-
tors of long-term post-operative use.31,32 Known risk factors for new 
chronic post-operative opioid use were further substantiated by the 
present study. These factors included female gender, BMI below 
18.5, BMI above 30.0, and pre-operative comorbidity. Contrary with 
existing literature, though still anticipated, was the association be-
tween intraoperative characteristics and immediate post-operative 
complications and the onset of chronic post-operative opioid use in 
pre-operative naïve patients.
The use of intraoperative epidural catheter did show a trend 
toward a decreased risk of chronic post-operative opioid use 
among pre-operative opioid naïve patients. Assuming that epidural 
F I G U R E  3   Number of opioid 
dispensings in the fourth postoperative 
quarter among chronic postoperative 
opioid users.
F I G U R E  4   Percentage of patient with at least one opioid dispensing in each postopeartive quarter stratified by year Western Denmark, 
2003-2016. Abbreviations: Q, quarter [Colour figure can be viewed at wileyonlinelibrary.com]
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catheters provide optimal post-operative pain treatment, this find-
ing supports current evidence showing that adequate post-op-
erative treatment limits the risk of chronic post-operative opioid 
use.10,11 Epidural catheters were used only in one of the four heart 
centers. Therefore, we cannot exclude that non-measured factors 
related to the operating hospital and the regional area other than use 
of epidural catheters explain the observed decrease risk of chronic 
post-operative opioid use.
Data on prescribing behaviors during hospitalization were not 
available for the present study population. Hence, our study results 
do not elicit if special prescribing patterns in the immediate post-op-
erative period increased the risk of chronic post-operative opioid 
use in pre-operative naïve patients.
Opioid use within the first month from discharge was highly as-
sociated with chronic post-operative opioid use in pre-operative opi-
oid naïve patients. Pre-operative naïve patients receiving more than 
500 mg OME had a more than threefold risk of becoming chronic 
post-operative opioid users compared to patients with no post-dis-
charge dispensing. These findings are very much aligned with reports 
from cardiothoracic patients published by Brescia et al describing the 
adjusted rate of new chronic post-operative users to be 19.6% among 
patients with intraoperative prescription size of more than 450 OME 
with a threshold effect between 300-450 OME and > 450 OME.28 
Our findings support their conclusion that post-discharge opioid 
prescription is a modifiable predictor of new chronic post-operative 
opioid use, and clinicians should certainly avoid prescribing more 
than 60 tablets of 5 mg Oxycodone for full sternotomy. However, 
more elaborated, patient-tailored and evidence-based prescribing 
guidelines are needed to respond to the risk of inducing new chronic 
post-operative opioid users among adult cardiac surgery patients.
4.3 | Clinical implications
Annually, more than 400 Danish patients become chronic post-
operative opioid users after cardiac surgery; noteworthy, many of 
these patients are new chronic opioid users. Preventive measures 
focused on patients who may be at higher risk for chronic post-
operative opioid use should be investigated and implemented. 
Possible modifying practices may include pre-operative biopsy-
chosocial programs to reduce opioid use in the post-operative 
period,33 and implementation of non-opioid pain treatment (eg 
F I G U R E  5   Odds ratios for pre-, intra-, and postopeartive risk factors for Abbreviations: CI, confidence interval; BMI, body mass index; 
ICU, intensive care unit at least one opioid dispensing in the forth postoperative quarter stratified by preopeartive opioid status. *No opioid 
dispensing within six months before cardiac surgery. †Defined as serum creatinine >200. ‡Includes pharmacologically treated diabetes 
mellitus type 1 and type 2. §Includes hemodialysis, peritoneal dialysis, and continuous veno-venous hemofiltration. ||Cumulative morphine 
equivalent opioid use within one month after cardiac surgery [Colour figure can be viewed at wileyonlinelibrary.com]
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regional nerve blocks in the intra- and immediate post-operative 
period). Opioids may not even be needed at the time of discharge, 
and if they are needed, clinicians should complement careful dis-
charge scripts.
4.4 | Strengths and weaknesses
A major strength of the present study is its multi-institutional study 
design covering an unselected patient population with free access 
to a universal healthcare system and with individual patient-data 
linkage. Furthermore, prospective data collection in the WDHR and 
complete patient follow-up minimized the risk of selection bias. The 
present study is based on prescription dispensings rather than on 
issued prescriptions, which provides an important advantage as a 
prescription dispensing is a better surrogate marker for actual drug 
intake than a written prescription.24 Another important feature of 
the NPR is its inclusion of drugs used by nursing home residents, 
which limits differential misclassification of exposure status due to 
frailty among elderly individuals.7
A limitation of this study is the lack of data on indication for opi-
oid use. Thus, it is likely that some late initiators took opioids for 
pain conditions unrelated to the cardiac surgical procedure. Further 
limitations include unavailability of data on intended duration, and 
whether the drug was taken as recommended by the prescriber. 
Another limitation is the unavailability of data on inpatient opioid 
use and opioids dispensed in hospitals.
5  | CONCLUSION
Chronic post-operative opioid use was observed in 5.7% (95% CI: 
5.5-6.0) of pre-operative opioid naïve patients, 68.3% (95% CI: 66.1-
70.4) in pre-operative low dose opioid users, and 76.3% (95% CI: 74.0-
78.5) in pre-operative high dose opioid users. Opioid use remained 
steady from the second post-operative quarter. Pre-operative opioid 
use and post-discharge opioid dispensing was highly associated with 
increased risk of chronic post-operative opioid use in pre-operative 
opioid naïve patients, and may present as modifiable factors that 
need more clinical attention in order to avoid new chronic post-op-
erative opioid users among the cardiac surgery population.
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APPENDIX 
Table A3 Distribution of post-operative opioid dispensings, Western Denmark, 2003-2016
Before cardiac surgery, 
n (%)
Post-operative quarter, n (%)
Q1 Q2 Q3 Q4
Total 13 076 (100) 17 256 (100) 8461 (100) 8061 (100) 8261 (100)
Opioid agonists
Morphine 1,268 (9.7) 2,229 (12.9) 1,073 (12.7) 1,054 (13.1) 1,067 (12.9)
Hydromorphone <3 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Nicomorphine 85 (0.7) 76 (0.4) 30 (0.4) 34 (0.4) 59 (0.7)
Oxycodone 1,699 (13.0) 3,649 (21.2) 1,491 (17.6) 1,395 (17.3) 1,439 (17.4)
Oxycodone and naloxone 8 (0.1) 5 (0.0) 4 (0.1) 3 (0.0) 4 (0.1)
Ketobemidone <3 (0.0) <3 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Pethidine 168 (1.3) 84 (0.5) 102 (1.2) 82 (1.0) 48 (0.6)
Fentanyl 254 (1.9) 210 (1.2) 267 (3.2) 280 (3.5) 311 (3.8)
Dextropropoxyphene 129 (1.0) 48 (0.3) 52 (0.6) 43 (0.5) 44 (0.5)
Pentazocine 0 (0.0) 4 (0.0) 0 (0.0) 0 (0.0) 3 (0.0)
Ketobemidone and antispasmodic 732 (5.6) 1007 (5.8) 387 (4.6) 380 (4.7) 377 (4.6)
Codeine and paracetamol 1,076 (8.2) 1095 (6.4) 625 (7.4) 610 (7.6) 576 (7.0)
Codeine and acetylsalicylic acid 147 (1.1) 32 (0.2) 27 (0.3) 49 (0.61) 46 (0.6)
Dual-action opioid agonists
Tramadol 7,067 (54.1) 8,609 (49.9) 4,157 (49.1) 3,867 (48.0) 4,016 (48.6)
Tapentadol 19 (0.2) 9 (0.1) 8 (0.1) 15 (0.2) 13 (0.2)
Partial opioid agonists
Buprenorphine 420 (3.2) 198 (1.2) 238 (2.8) 249 (3.1) 258 (3.1)
Abbreviations: n, number; Q, quarter.
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Table A4 Pre-operative risk factors of fourth quarter post-oper-
ative opioid use stratified by pre-operative opioid status, Western 
Denmark, 2003-2016
Variable
Pre-operative opioid 
naïvea , OR (95% CI)
Pre-operative opioid 
user, OR (95% CI)
Gender
Male 1 (ref.) 1 (ref.)
Female 1.3 (1.2-1.5) 1.6 (1.4-1.9)
Age
<60 1 1
60-70 1.1 (0.9-1.3) 1.1 (0.9-1.3)
>70 1.0 (0.9-1.2) 1.1 (0.9-1.3)
BMI
18.5-24.9 1 1
<18.5 1.4 (1.1-1.8) 1.4 (1.0-1.9)
25.0-29.9 1.1 (1.0-1.3) 1.1 (0.9-1.3)
≥30.0 1.5 (1.3-1.8) 1.5 (1.2-1.8)
Chronic obstructive pulmonary disease
No 1 1
Yes 1.8 (1.5-2.1) 1.3 (1.1-1.6)
Peripheral artery disease
No 1 1
Yes 1.8 (1.6-2.1) 1.4 (1.1-1.7)
Chronic kidney failureb 
No 1 1
Yes 1.9 (1.4-2.6) 1.2 (0.8-1.8)
Diabetesc 
No 1 1
Yes 1.4 (1.2-1.7) 1.3 (1.1-1.5)
Left ventricle ejection fraction
≥50 1 1
31-50 1.2 (1.0-1.3) 0.9 (0.8-1.1)
≤30 1.3 (1.0-1.6) 1.3 (0.9-1.7)
Pulmonary hypertension
No 1 1
Yes 1.4 (1.1-1.7) 1.0 (0.7-1.2)
Abbreviations: BMI, body mass indexCI, confidence interval; OR, odds 
ratio.
aNo opioid dispensing within six months before cardiac surgery. 
bDefined as serum creatinine > 200. 
cIncludes pharmacologically treated diabetes mellitus type 1 and type 2. 
TA B L E  A 5   Intra- and post-operative risk factors of fourth 
quarter post-operative opioid use stratified by pre-operative opioid 
status, Western Denmark, 2003-2016
Variable
Preoperative opioid 
naïvea , OR (95% CI)
Preoperative opioid 
user, OR (95% CI)
Acute surgery
No 1 (ref.) 1 (ref.)
Yes 1.3 (1.0-1.5) 0.8 (0.6-1.0)
Surgery type
CABG, without 
valve surgery
1 1
Combinations 
and other
1.0 (0.9-1.1) 1.1 (0.9-1.2)
Epidural
No 1 1
Yes 0.8 (0.6-1.0) 1.2 (0.9-1.5)
Extra corporeal circulation
Off pump 1 1
On pump 0.8 (0.7-1.0) 0.9 (0.8-1.1)
ICU-time
≤1 day 1 1
>1 day 1.5 (1.3-1.7) 1.0 (0.9-1.2)
Myocardial infarction
No 1 1
Yes 1.2 (0.9-1.7) 1.1 (0.7-1.6)
Renal replacement therapyb 
No 1 1
Yes 1.8 (1.4-2.5) 0.8 (0.5-1.3)
Reoperation
No 1 1
Yes 1.1 (0.9-1.3) 1.4 (1.0-1.8)
Sternal wound infection
No 1 1
Yes 2.1 (1.4-3.2) 1.0 (0.6-1.8)
Stroke
No 1 1
Yes 2.1 (1.5-2.9) 1.2 (0.7-2.1)
Post-discharge opioid usec 
0 mg. 1 1
1-500 mg. 1.8 (1.6-2.0) 1.7 (1.4-2.0)
>500 mg. 3.3 (2.8-4.0) 5.5 (4.5-6.7)
Abbreviations: CI, confidence interval; OR, odds ratio.
aNo opioid dispensing within six months before cardiac surgery. 
bIncludes hemodialysis, peritoneal dialysis, and continuous veno-venous 
hemofiltration. 
cCumulative morphine equivalent opioid use within one month after 
cardiac surgery. 
